Jennifer Tousignant

Companies

• Viridian Therapeutics, Inc.\DEGeneral counsel Feb 14, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTViridian Therapeutics, Inc.\DE VRDN0 shares²Aug 19, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 19, 2026Sold 10,000 shares at $24.50 of Viridian Therapeutics, Inc.\DE²
• Aug 19, 2026Exercised options 10,000 shares at $14.41 of Viridian Therapeutics, Inc.\DE²
• Aug 19, 2026Sold 4,212 shares at $24.50 of Viridian Therapeutics, Inc.\DE²
• Mar 3, 2026Shares withheld for tax 1,724 shares at $29.32 of Viridian Therapeutics, Inc.\DE³
• Mar 3, 2026Shares withheld for tax 1,675 shares at $30.19 of Viridian Therapeutics, Inc.\DE⁴
• Mar 3, 2026Exercised options 5,169 shares of Viridian Therapeutics, Inc.\DE³
• Dec 31, 2025Sold 2,272 shares at $31.16 of Viridian Therapeutics, Inc.\DE⁵